CNBC Television
@CNBCtelevision·3.4M subscribers·157.5K videos
Novartis shares up following positive trial data of new multiple sclerosis drug
Posted
September 1, 2026
Views
305
Likes
3
Engagement
0.98%
September 1, 2026
305
3
0.98%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:02Now PlayingShares of Novartis rose on Tuesday after a positive clinical trial readout for its multiple sclerosis drug, despite reports that the drugmaker has paused another experimental treatment after three patients died.
CNBC's Annika Kim Constantino explains.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
